Surgery Partners (SGRY) Price & Analysis

Compare

371 Followers

SGRY Stock Chart & Stats

$15.71

$0.26(1.26%)

At close: Jan 08 4:00 PM EST

$15.71

$0.26(1.26%)

Day’s Range― - ―

52-Week Range$14.94 - $26.16

Previous CloseN/A

Volume149.01K

Average Volume (3M)1.48M

Market Cap

$2.03B

Enterprise Value$8.24B

Total Cash (Recent Filing)$203.40M

Total Debt (Recent Filing)$3.87B

Price to Earnings (P/E)―

Beta1.19

Next Earnings

Mar 02, 2026

EPS Estimate

0.3

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.13

Shares Outstanding129,341,780

10 Day Avg. Volume919,357

30 Day Avg. Volume1,482,625

Financial Highlights & Ratios

PEG Ratio-0.01

Price to Book (P/B)1.49

Price to Sales (P/S)0.86

P/FCF Ratio12.73

Enterprise Value/Market Cap4.06

Enterprise Value/Revenue2.51

Enterprise Value/Gross Profit10.48

Enterprise Value/Ebitda10.10

Forecast

1Y Price Target

$25.22

Price Target Upside60.53% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering10

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Cost ReductionLower supply costs from procurement initiatives and lower G&A related to reduced stock and incentive-based comp offset the margin pressure from a higher level of Medicare revenue.

Interest Expense ReductionA repricing of the term loan and revolver will reduce annual interest expense by $5-$6M going forward.

Portfolio OptimizationThe investment story on the stock and driver of upside primarily center on upcoming asset divestitures and the resulting de-leveraging of the company's balance sheet.

Bears Say

Earnings VisibilityLower than expected performance and lower earnings visibility due to payer mix pressure are leading to reduced estimates for SGRY.

Revenue ShortfallThe revenue/volume shortfall is occurring mostly in SGRY's commercial book of business.

Valuation ConcernsThe price target for SGRY has been lowered to $22, reflecting a valuation below its ten-year average trading low.

Surgery Partners News

Surgery Partners price target lowered to $19 from $22 at Mizuho

Mizuho lowered the firm’s price target on Surgery Partners (SGRY) to $19 from $22 and keeps an Outperform...

23d ago

SGRY

Surgery Partners Issues $425M Senior Notes for Flexibility

The latest update is out from Surgery Partners ( ($SGRY) ). On December 16, 2025, Surgery Center Holdings,...

25d ago

SGRY

Surgery Partners Prices $425M Senior Notes Offering

Surgery Partners ( ($SGRY) ) has shared an update. On December 11, 2025, Surgery Partners, Inc. announced the...

29d ago

SGRY

Surgery Partners Announces $425M Senior Notes Offering

The latest update is out from Surgery Partners ( ($SGRY) ). On December 11, 2025, Surgery Partners, Inc....

1M ago

SGRY

Surgery Partners announces add-on senior notes offering

Surgery Partners (SGRY) announced that Surgery Center Holdings, a wholly owned subsidiary of the Company, intends to offer,...

1M ago

SGRY

Surgery Partners, Baylor Scott & White Health form joint venture

Surgery Partners (SGRY) announces a new partnership with Baylor Scott & White Health to jointly own with physicians...

1M ago

SGRY

Surgery Partners price target lowered to $20 from $27 at JPMorgan

JPMorgan lowered the firm’s price target on Surgery Partners (SGRY) to $20 from $27 and keeps a Neutral...

2M ago

SGRY

Short Report: Core Scientific short interest at record high

Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest...

2M ago

CAR

CELC

Surgery Partners price target lowered to $18 from $24 at Barclays

Barclays lowered the firm’s price target on Surgery Partners (SGRY) to $18 from $24 and keeps an Equal...

2M ago

SGRY

Surgery Partners price target lowered to $22 from $28 at Mizuho

Mizuho lowered the firm’s price target on Surgery Partners (SGRY) to $22 from $28 and keeps an Outperform...

2M ago

SGRY

Surgery Partners price target lowered to $29 from $34 at UBS

UBS lowered the firm’s price target on Surgery Partners (SGRY) to $29 from $34 and keeps a Buy...

2M ago

SGRY

Surgery Partners Appoints New COO and President

Surgery Partners ( ($SGRY) ) has issued an announcement. On November 12, 2025, Surgery Partners, Inc. announced the...

2M ago

SGRY

Strategic Growth and Portfolio Optimization Drive Buy Rating for Surgery Partners

Analyst Ryan Langston of TD Cowen maintained a Buy rating on Surgery Partners, retaining the price target of...

2M ago

SGRY

Surgery Partners price target lowered to $31 from $35 at RBC Capital

RBC Capital lowered the firm’s price target on Surgery Partners (SGRY) to $31 from $35 but keeps an...

2M ago

SGRY

SGRY FAQ

What was Surgery Partners Inc’s price range in the past 12 months?

Surgery Partners Inc lowest stock price was $14.94 and its highest was $26.16 in the past 12 months.

What is Surgery Partners Inc’s market cap?

Surgery Partners Inc’s market cap is $2.03B.

When is Surgery Partners Inc’s upcoming earnings report date?

Surgery Partners Inc’s upcoming earnings report date is Mar 02, 2026 which is in 51 days.

How were Surgery Partners Inc’s earnings last quarter?

Surgery Partners Inc released its earnings results on Nov 10, 2025. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.203 by -$0.073.

Is Surgery Partners Inc overvalued?

According to Wall Street analysts Surgery Partners Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Surgery Partners Inc pay dividends?

Surgery Partners Inc does not currently pay dividends.

What is Surgery Partners Inc’s EPS estimate?

Surgery Partners Inc’s EPS estimate is 0.3.

How many shares outstanding does Surgery Partners Inc have?

Surgery Partners Inc has 129,341,780 shares outstanding.

What happened to Surgery Partners Inc’s price movement after its last earnings report?

Surgery Partners Inc reported an EPS of $0.13 in its last earnings report, missing expectations of $0.203. Following the earnings report the stock price went down -25.395%.

Which hedge fund is a major shareholder of Surgery Partners Inc?

Currently, no hedge funds are holding shares in SGRY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Surgery Partners Stock Smart Score

Neutral

Fundamentals

Return on Equity

-9.45%

Trailing 12-Months

Asset Growth

5.47%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Surgery Partners Inc

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Surgery Partners (SGRY) Earnings & Revenues

Historic Earnings Reports

SGRY Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call presented a mixed picture with solid revenue and EBITDA growth, strong performance in surgical cases, and significant capital deployment in growth areas. However, the company faces challenges with softer than expected volume growth, unfavorable payer mix changes, delayed capital deployment, and regulatory delays impacting new facilities. These challenges have led to a revision in full-year guidance.View all SGRY earnings summaries

SGRY Stock 12 Month Forecast

Average Price Target

$25.22

▲(60.53% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","20":"$20","24":"$24","28":"$28","32":"$32"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$31.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$25.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,20,24,28,32],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.1,18.169230769230772,19.23846153846154,20.30769230769231,21.376923076923077,22.446153846153848,23.51538461538462,24.584615384615386,25.653846153846153,26.723076923076924,27.792307692307695,28.861538461538462,29.930769230769233,{"y":31,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.1,17.724615384615387,18.349230769230772,18.973846153846154,19.59846153846154,20.223076923076924,20.84769230769231,21.472307692307695,22.096923076923076,22.72153846153846,23.346153846153847,23.97076923076923,24.595384615384617,{"y":25.22,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.1,17.169230769230772,17.23846153846154,17.30769230769231,17.376923076923077,17.446153846153848,17.515384615384615,17.584615384615386,17.653846153846153,17.723076923076924,17.79230769230769,17.861538461538462,17.93076923076923,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.81,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.17,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.49,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.08,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.48,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.43,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.39,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.55,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.28,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.18,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.93,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.1,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >